AIDS Healthcare Foundation (AHF) will hold an in-person and virtual press conference at the AHF booth (#111) during the 2024 International AIDS Conference (AIDS 2024) on Tuesday, July 23, at 13:15 CEST (7:15 a.m. US EDT) in Munich, Germany, at…
Rusan Pharma, an India-based pharmaceutical company specializing in addiction treatment and pain management, recently announced that the United States Food and Drug Administration (USFDA) has granted Good Manufacturing Practice (GMP) approval for its Active Pharmaceutical Ingredient (API) facility in Ankleshwar,…
The WHO is actively participating in the 25th International AIDS Conference (AIDS 2024) in Munich, Germany, and online from July 20 to 26. During a series of pre-conference sessions and WHO-led satellite events, the Organization will present its latest epidemiological…
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino) announced today that its Korean subsidiary, Ono Pharma Korea Co., Ltd. (OPKR), received additional approval from South Korea’s Ministry of Food and Drug Safety (MFDS) on July 17. The approval…
Labcorp, a leading global life sciences company, has been recognized as a top employer for disability inclusion by achieving a perfect score of 100 on the 2024 Disability Equality Index®. The Disability Equality Index, established by Disability and the American…
BeiGene, a global oncology company, has announced the appointment of Aaron Rosenberg as Chief Financial Officer, effective July 22. Rosenberg will succeed Julia Wang, who is leaving to pursue other opportunities but will remain with the company through August to…
Global pharmaceutical leader Lupin Limited (Lupin) has announced the approval of its Abbreviated New Drug Application by the United States Food and Drug Administration (U.S. FDA) for Topiramate Extended-Release Capsules. This approval covers dosages of 25 mg, 50 mg, 100…
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) has announced a definitive agreement to acquire APEIRON Biologics AG for $100 million in cash. APEIRON holds royalty rights to QARZIBA® (dinutuximab beta), a treatment for high-risk neuroblastoma. In addition to the initial payment, Ligand…
Epsilogen Receives CTA Approval for Phase Ib Trial of MOv18 IgE in Platinum-Resistant Ovarian Cancer Epsilogen has announced that it has received Clinical Trial Authorization (CTA) approval for a Phase Ib study to evaluate the efficacy of MOv18 IgE in…
Neuranics, a pioneering deep tech startup based in Glasgow, proudly announced its prestigious accolade as the Deep Tech Investment of the Year at the UK Angel Investment Awards. The ceremony, held at the Science Museum London, underscored Neuranics’ rapid ascent…
Axena Health Secures Expanded Insurance Coverage for Leva Pelvic Health System Axena Health, Inc. (Axena Health) has achieved a significant milestone in expanding insurance coverage for its Leva® Pelvic Health System. Two major health plans in Pennsylvania and North Dakota…
The latest addition to ResearchAndMarkets.com’s offerings is the “Hospital Care Collaboration and Licensing Deals 2016-2024” report, now fully revised and updated. This comprehensive report delves into hospital care deals spanning the years 2016 to 2024, providing unprecedented insights into collaborations…
